BPG is committed to discovery and dissemination of knowledge
Articles in Press
6/3/2026 9:37:22 AM | Browse: 0 | Download: 0
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Basic Study |
| Article Title |
Mesenchymal stem cells therapy ameliorates esophageal dysmotility in gastroesophageal reflux disease by modulating smooth muscle contractility, alleviating senescence by targeting the DNMT3a-HIF1α axis
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Yi Li, Wen-Ya Zhu, Bo Zhang, Ze-Rui Wang, Zhao-Yang Chen, Qian-Qian Chen and En-Qiang Linghu |
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| China Postdoctoral Science Foundation |
2020TQ0131 |
| Natural Science Foundation of Beijing Municipality |
7232151 |
|
| Corresponding Author |
En-Qiang Linghu, Department of Gastroenterology, The First Medical Center, General Hospital of the Chinese PLA, No. 28 Fuxing Road, Haidian District, Beijing 100853, China. linghuenqiang@vip.sina.com |
| Key Words |
Mesenchymal stem cells; Gastroesophageal reflux disease; Esophageal dysmotility; DNA methyltransferase 3a/hypoxia-inducible factor 1 alpha axis |
| Core Tip |
This work shows mesenchymal stem cells (MSCs) restore impaired esophageal contractility and reduce inflammation in gastroesophageal reflux disease by regulating ion channels and smooth muscle proteins. MSCs counteract tumor necrosis factor-α-accelerated cell senescence and dysfunction, with DNA methyltransferase 3a and hypoxia-inducible factor 1 alpha pathways implicated. These results uncover critical mechanisms for MSC-mediated regenerative effects, proposing a promising cell-based therapeutic approach for restoring physiological function in gastroesophageal reflux disease. |
| Citation |
Li Y, Zhu WY, Zhang B, Wang ZR, Chen ZY, Chen QQ, Linghu EQ. Mesenchymal stem cells therapy ameliorates esophageal dysmotility in gastroesophageal reflux disease by modulating smooth muscle contractility, alleviating senescence by targeting the DNMT3a-HIF1α axis. World J Stem Cells 2026; In press
|
 |
Received |
|
2026-03-13 01:49 |
 |
Peer-Review Started |
|
2026-03-13 01:49 |
 |
First Decision by Editorial Office Director |
|
2026-03-26 10:15 |
 |
Return for Revision |
|
2026-03-26 10:15 |
 |
Revised |
|
2026-04-07 11:05 |
 |
Publication Fee Transferred |
|
2026-04-13 11:43 |
 |
Second Decision by Editor |
|
2026-05-25 02:42 |
 |
Second Decision by Editor-in-Chief |
|
|
 |
Final Decision by Editorial Office Director |
|
2026-06-03 09:37 |
 |
Articles in Press |
|
2026-06-03 09:37 |
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
|
| ISSN |
1948-0210 (online) |
| Open Access |
This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc. |
| Copyright |
©Author(s) (or their employer(s)) 2026. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc. |
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.